AstraZeneca launches patented life-saving heart drug in India
Brilinta is indicated to reduce heart attack and cardiovascular death in patients with Acute Coronary Syndromes
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Maharashtra to stop issuing license to branded drugs from October 20, 2012
IDMA-GSB to conduct extraordinary EC meeting tomorrow
Ministry of Commerce and Industry, GoI, urges Indian pharma cos to explore non-regulated markets
It is targeted that by 2015, the Indian pharma export will touch $25 billion
Karnataka State Drug Control Department to introduce e-governance software
Software to be launched on November 1, 2012
Mentoring meet for IKP-GCE in Bangalore
Organisers are looking to identify, fund and nurture healthcare innovations in India
Indegene to host Pharma Future India Chapter Conclave 2012
Event to be held in Mumbai on October 19, 2012
Lupin receives FDA approval for Generic Avapro tabs
Lupin announced today that its subsidiary Lupin Pharmaceuticals has received final approval for its Irbesartan Tablets
Drug-eluting angioplasty treatment for peripheral artery disease shows promise
In the DEBELLUM trial, 50 patients were randomly assigned to either conventional angioplasty or the DEB procedure
Trophos programme receives 1 million euro grant for olesoxime in progressive Multiple Sclerosis
Agence Nationale de la Recherche awards second grant to Trophos led consortium for Phase Ib/IIa clinical study